temp_copy

*This post was originally posted on the Neuroethics Women (NEW Leaders) Leaders site . Recently, I composed a piece for Nature Science Soapbox entitled, Placebo for Psychogenic Illnesses: Why "It's all in my head" does and doesn't matter and in the Huffington Post on Placebo . Both pieces work to reframe and deepen our understanding of medicine and illness by utilizing neuroscience. Importantly, this process must include humility for the limitations of neuroscience and our current understanding of the brain while also maintaining an openness to what we don't know, avoiding foreclosing opportunities for richer understanding of the brain's capabilities. I believe neuroethics discourse needs to occur with all relevant stakeholders, and as I discussed with colleagues recently, I feel it would be a failure if I couldn't engage in neuroethics discourse outside of my discipline (I admit that I'm well-rooted in neuroscience). I've had colleagues voice conc...

*Deadline for abstract submissions: May 15, 2012 *  Brain Matters 3:  Values at the Crossroads of Neurology, Psychiatry and Psychology  October 24th-25th, 2012 This conference provides a venue for collaboration and learning in the area of neuroethics. The plenary speakers of this conference will address ethical challenges in the treatment and research for conditions with neurological symptomatology but that are without identifiable biological correlates/causes. The complexities of suffering and disability experienced by individuals with these conditions are significant, including exposure to dangerous and futile treatments. Parallel sessions will include accepted abstracts from a broad range of neuroethics interests.  At this conference, presentations will be given by patients, physicians, neuroscientists, and ethicists and is intended to appeal to a broad audience.  Please see the call for abstracts and conference information at  ...